| |
| |
|
| Insider
Information: |
Gardner Phyllis |
| Relationship: |
Director |
| City: |
Stanford |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
133,524 |
|
|
Indirect Shares
|
457,085 |
|
|
| Direct
Value |
$789,840 |
|
|
|
Indirect Value
|
$1,554,089 |
|
|
| Total
Shares |
590,609 |
|
|
| Total
Value |
$2,343,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Revance Therapeutics, Inc. |
RVNC |
Director |
2020-05-14 |
16,500 |
2014-02-11 |
457,085 |
Premium* |
|
|
Corium International, Inc. |
CORI |
Director |
2018-11-27 |
0 |
2015-03-27 |
0 |
Premium* |
|
|
Mimedx Group Inc |
MDXG |
Director |
2023-06-13 |
117,024 |
2021-04-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2023-06-13 |
4 |
A |
$4.95 |
$175,002 |
D/D |
35,354 |
117,024 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2022-06-07 |
4 |
A |
$3.96 |
$174,996 |
D/D |
44,191 |
81,670 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
37,479 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2021-04-28 |
4 |
A |
$10.71 |
$218,730 |
D/D |
20,423 |
20,423 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,500 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
10,500 |
0 |
- |
|
| CORI |
Corium International, Inc... |
Director |
– • – |
2018-11-27 |
4 |
D |
$12.50 |
$427,538 |
D/D |
(34,203) |
0 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,000 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2018-03-16 |
4 |
S |
$31.51 |
$168,045 |
D/D |
(5,333) |
3,000 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2018-03-16 |
4 |
OE |
$2.55 |
$13,599 |
D/D |
5,333 |
8,333 |
0 |
- |
|
| CORI |
Corium International, Inc... |
Director |
– • – |
2017-08-21 |
4 |
OE |
$2.12 |
$70,129 |
D/D |
33,064 |
34,203 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| CORI |
Corium International, Inc... |
Director |
– • – |
2015-03-27 |
4 |
OE |
$0.20 |
$230 |
D/D |
1,139 |
1,139 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2014-02-11 |
4 |
OE |
$0.00 |
$0 |
I/I |
12,839 |
457,085 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2014-02-11 |
4 |
A |
$0.00 |
$0 |
I/I |
444,246 |
444,246 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
